The Coronary Artery Bypass Grafts Market is witnessing steady growth, driven by the increasing global burden of cardiovascular diseases and continuous advancements in cardiac surgical technologies. Coronary artery bypass grafting (CABG) remains one of the most effective surgical procedures for treating severe coronary artery disease (CAD), particularly in patients with complex multi-vessel blockages. With rising awareness, improved diagnostic capabilities, and enhanced surgical outcomes, CABG continues to play a crucial role in modern cardiovascular care.

Market Value and Growth Outlook

The Coronary Artery Bypass Grafts market size is expected to reach US$ 28.88 billion by 2033 from US$ 16.94 billion in 2025. The market is estimated to record a CAGR of 6.89% from 2026 to 2033, reflecting consistent demand across developed and emerging economies. This growth trajectory is supported by increasing procedural volumes, expanding healthcare infrastructure, and the growing adoption of advanced CABG technologies.

Rising Prevalence of Coronary Artery Disease Globally

One of the primary drivers fueling the Coronary Artery Bypass Grafts Market is the rising prevalence of coronary artery disease worldwide. Sedentary lifestyles, unhealthy dietary habits, obesity, smoking, diabetes, and hypertension have significantly increased the incidence of CAD across all age groups. According to global health organizations, cardiovascular diseases remain the leading cause of mortality, prompting healthcare systems to prioritize effective interventional and surgical treatments such as CABG. As disease severity rises, especially in patients with complex arterial blockages, the demand for bypass grafting procedures continues to grow.

Growing Geriatric Population Drives CABG Demand

The rapidly expanding geriatric population is another major factor contributing to market growth. Older adults are more susceptible to atherosclerosis and advanced coronary artery disease, often requiring surgical intervention when pharmacological or minimally invasive treatments prove insufficient. As life expectancy increases globally, especially in regions such as North America, Europe, and parts of Asia-Pacific, hospitals are witnessing higher volumes of CABG surgeries. This demographic shift is directly boosting demand for grafts, stabilizers, retractors, and other essential CABG devices.

Advances in Graft and Surgical Techniques

Technological advancements in graft materials and surgical techniques have significantly improved procedural success rates and patient outcomes. Innovations such as arterial grafts, minimally invasive CABG, off-pump procedures, and enhanced tissue stabilizers are reducing complications, shortening hospital stays, and improving recovery times. The growing preference for off-pump CABG due to reduced neurological and renal risks is further accelerating adoption of advanced surgical tools and devices, strengthening overall market expansion.

Segments Covered

By Product

Grafts

Retractors

Heart Positioners

Tissue Stabilizers

Other Products

Among product categories, grafts hold a dominant market share due to their critical role in restoring blood flow. Tissue stabilizers and heart positioners are also gaining traction with the increasing adoption of minimally invasive and off-pump CABG procedures.

By Surgical Procedure

Single CABG Surgery

Double CABG Surgery

Triple CABG Surgery

Quadruple CABG Surgery

Triple and quadruple CABG surgeries account for a significant portion of the market, reflecting the rising incidence of multi-vessel coronary artery disease globally.

By Technology

On-Pump CABG

Off-Pump CABG

Other Technologies

Off-pump CABG is experiencing robust growth due to reduced post-operative complications and improved patient safety, particularly among elderly and high-risk patients.

By End User

Hospitals

Cardiology Clinics

Research Institutes

Other End Users

Hospitals dominate the end-user segment, supported by advanced surgical infrastructure, skilled cardiac surgeons, and higher procedural volumes.

Market Leaders and Key Company Profiles

The Coronary Artery Bypass Grafts Market is moderately consolidated, with leading players focusing on product innovation, strategic collaborations, and geographic expansion. Key companies include Medtronic Plc, Johnson & Johnson (Ethicon), Terumo Corporation, Getinge AB, LivaNova Plc, B. Braun Melsungen AG, and Stryker Corporation. These companies offer comprehensive CABG solutions, including grafts, stabilizers, and advanced surgical systems, catering to the evolving needs of cardiac surgeons worldwide.

Future Outlook

The future of the Coronary Artery Bypass Grafts Market remains promising, supported by rising CAD prevalence, an aging global population, and continuous innovation in cardiac surgery. Emerging economies are expected to offer significant growth opportunities due to improving healthcare access and increasing investments in cardiac care infrastructure. As technology continues to advance and awareness of surgical treatment options grows, the market is poised for sustained expansion through 2033.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact us:

  • If you have any questions about this report or would like further information, please contact us:
  • Contact person: Ankit Mathur
  • Email: sales@businessmarketinsights.com
  • Phone: +16467917070